In conclusion, we demonstrated that the Arg16/Gln27 haplotype in ADRB2 was associated with a reduced risk of exacerbation in COPD patients treated with inhaled β2-agonists. Here, ADRB2 is linked to chronic obstructive pulmonary disease.